1. Home
  2. NBTX vs NNY Comparison

NBTX vs NNY Comparison

Compare NBTX & NNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NBTX
  • NNY
  • Stock Information
  • Founded
  • NBTX 2003
  • NNY 1987
  • Country
  • NBTX France
  • NNY United States
  • Employees
  • NBTX N/A
  • NNY N/A
  • Industry
  • NBTX Biotechnology: Pharmaceutical Preparations
  • NNY Investment Managers
  • Sector
  • NBTX Health Care
  • NNY Finance
  • Exchange
  • NBTX Nasdaq
  • NNY Nasdaq
  • Market Cap
  • NBTX 178.7M
  • NNY 156.0M
  • IPO Year
  • NBTX 2020
  • NNY N/A
  • Fundamental
  • Price
  • NBTX $3.41
  • NNY $8.29
  • Analyst Decision
  • NBTX Strong Buy
  • NNY
  • Analyst Count
  • NBTX 1
  • NNY 0
  • Target Price
  • NBTX $8.00
  • NNY N/A
  • AVG Volume (30 Days)
  • NBTX 7.6K
  • NNY 50.9K
  • Earning Date
  • NBTX 04-02-2025
  • NNY 01-01-0001
  • Dividend Yield
  • NBTX N/A
  • NNY 4.04%
  • EPS Growth
  • NBTX N/A
  • NNY N/A
  • EPS
  • NBTX N/A
  • NNY N/A
  • Revenue
  • NBTX N/A
  • NNY N/A
  • Revenue This Year
  • NBTX N/A
  • NNY N/A
  • Revenue Next Year
  • NBTX $221.06
  • NNY N/A
  • P/E Ratio
  • NBTX N/A
  • NNY N/A
  • Revenue Growth
  • NBTX N/A
  • NNY N/A
  • 52 Week Low
  • NBTX $2.76
  • NNY $7.58
  • 52 Week High
  • NBTX $7.51
  • NNY $8.87
  • Technical
  • Relative Strength Index (RSI)
  • NBTX 55.19
  • NNY 68.69
  • Support Level
  • NBTX $3.26
  • NNY $8.13
  • Resistance Level
  • NBTX $3.65
  • NNY $8.40
  • Average True Range (ATR)
  • NBTX 0.19
  • NNY 0.07
  • MACD
  • NBTX 0.03
  • NNY 0.03
  • Stochastic Oscillator
  • NBTX 43.75
  • NNY 90.48

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

About NNY Nuveen New York Municipal Value Fund

Nuveen New York Municipal Value Fund Inc is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from both regular federal and New York state income taxes, by investing primarily in a portfolio of municipal obligations issued by state and local government authorities within the state of New York or certain U.S. territories.

Share on Social Networks: